APA (7th ed.) Citation

Ross, D. M., & Saußele, S. (2018). Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study. Journal of cancer research and clinical oncology, 144(5), . https://doi.org/10.1007/s00432-018-2604-x

Chicago Style (17th ed.) Citation

Ross, David M., and Susanne Saußele. "Durable Treatment-free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase Following Frontline Nilotinib: 96-week Update of the ENESTfreedom Study." Journal of Cancer Research and Clinical Oncology 144, no. 5 (2018). https://doi.org/10.1007/s00432-018-2604-x.

MLA (9th ed.) Citation

Ross, David M., and Susanne Saußele. "Durable Treatment-free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase Following Frontline Nilotinib: 96-week Update of the ENESTfreedom Study." Journal of Cancer Research and Clinical Oncology, vol. 144, no. 5, 2018, https://doi.org/10.1007/s00432-018-2604-x.